Table 6.

Reasons for Removing Patients From Study

Reason Percent of Patients
HHT/IFN-α IFN-α Historical Controls
Hematologic resistance  24  32  
Cytogenetic resistance6-150 10  10  
Toxicity  9  9  
Accelerated/blast phase 9  8  
Stem cell transplant  7  1  
Other  8 6 
Reason Percent of Patients
HHT/IFN-α IFN-α Historical Controls
Hematologic resistance  24  32  
Cytogenetic resistance6-150 10  10  
Toxicity  9  9  
Accelerated/blast phase 9  8  
Stem cell transplant  7  1  
Other  8 6 
F6-150

CHR, but no cytogenetic response.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal